Brett Finlay, University of British Columbia: The role of the microbiota in enteric and allergic diseases

Brett Finlay, University of British Columbia
Tuesday, February 5, 2013, 12:00 PM to 1:00 PM
Location: 240 Physical Sciences Building

Dr. B. Brett Finlay is a Professor in the Michael Smith Laboratories, and the Departments of Biochemistry and Molecular Biology, and Microbiology and Immunology at the University of British Columbia. His research interests are focussed on host-pathogen interactions, at the molecular level. By combining cell biology with microbiology, he has been at the forefront of the emerging field called Cellular Microbiology, making several fundamental discoveries in this field, and publishing over 300 papers. His laboratory studies several pathogenic bacteria, with Salmonella and pathogenic E. coli interactions with host cells being the primary focus. He is well recognized internationally for his work, and has won several prestigious awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, a MRC Scientist, five Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the IDSA Squibb award, the Jacob Biely Prize, is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences, an Officer of Canada and awarded the Order of BC, and is the UBC Peter Wall Distinguished Professor. He is a cofounder of?Inimex Pharmaceuticals, Inc., and Director of the?SARS Accelerated Vaccine Initiative. He also serves on several editorial and advisory boards, and is a strong supporter of communicating science to the public.

Source: http://cbse.soe.ucsc.edu/events/event/2437

custer scott walker restaurant week type 2 diabetes occupy congress juan williams victor martinez